Dichloroacetate (DCA), a PDK inhibitor, reactivates oxidative phosphorylation in VHL-deficient ccRCC by suppressing HIF-mediated glycolytic dominance [99]. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.